

Explore by topic
2021 — Record year; rerating
Record Group performance (sales €78.6bn; EBIT before special items ~€7.8bn) and an increased dividend proposal of €3.40 drove major price moves, supported by strong price realization across segments and buyback/return talk. The market began treating BASF as a cyclically strong chemicals compounder with pricing power, a narrative shift that commanded a premium on capital. The share traded steadily upward through 2021, closing near €61.78 [5, 7].
Jan–Feb 2022 — Peak and buyback signal
The Board resolved a €3bn share buyback (announced 4 Jan 2022; execution from 11 Jan 2022), which propelled the share to a multi-month high of €68.69 on 11 Feb 2022. The buyback combined with strong 2021 results created a near-term bullish narrative around value and shareholder returns. The stock broke out cleanly from its ~€60 base into the ~€68.7 peak [55, 67, 4].
H1–H2 2022 → 2023 Q1 — Geopolitical shock and Wintershall Dea impairment
Russia/Ukraine fallout forced BASF to wind down operations in Russia and Belarus during 2022. Wintershall Dea exposure triggered very large non-cash impairments (~€7.3bn on the holding) disclosed in preliminary FY-2022 figures, swinging net income negative. The earnings shock and impairment risk damaged investor confidence severely. The market rotated sharply from "pricing-power compounder" to a story dominated by geopolitical risk and energy exposure concerns. A sharp multi-month downtrend began as the market repriced political and commodity risk [2, 11, 4].
Feb 2023 — Buyback stopped, cost cuts
The Board terminated the 2022–23 buyback early on 24 Feb 2023 and announced ~2,600 job cuts as management prioritized liquidity and restructuring. Approximately 25.8m shares (≈€1.4bn) had been executed prior to the stop. The moves signaled necessary but defensive repositioning, with investors interpreting them as evidence of weaker near-term growth and earnings visibility. Renewed volatility and downside pressure followed as capital-return expectations were reset [57, 56, 19].
Late 2023 — Deal to separate E&P announced; weak operating year
Wintershall Dea impairments and restructuring continued through 2023. On 21 Dec 2023, BASF and LetterOne agreed a business combination transferring Wintershall Dea's E&P assets to Harbour Energy at an $11.2bn enterprise value—the principal de-risking catalyst. Group sales fell to ~€68.9bn with EBIT before special items at ~€3.8bn. The market moved toward a "derisk and simplify" narrative, viewing the Harbour sale as a pathway to decouple oil & gas exposure, though consensus expected structurally lower near-term profitability. Relief rallies occurred around the announcement, though the stock remained below the 2022 peak [16, 53, 21].
2024 — Management reset and closing of the E&P carve-out
Dr. Markus Kamieth became Chairman/CEO on 25 Apr 2024. The Harbour transaction completed on 3 Sep 2024, with BASF receiving cash and Harbour shares for a listed monetization route. The combination materially changed BASF's headline risk profile by separating most non-core upstream assets. The market's narrative shifted to "portfolio focus and execution," with attention on margin recovery, cost discipline and capital returns once de-risking was complete. A partial relief rally followed the closing and management clarity, though the stock did not re-test early-2022 highs [33, 34, 46].
2025 → mid-2026 — Consolidation and capital-return emphasis
Post-deal consolidation continued with ongoing cost discipline and renewed emphasis on shareholder returns. Management pursued buybacks and dividend programs, signaling multi-year capital-return plans. May 2026 reporting showed buyback activity and commitments to sizable returns over coming years, supporting valuation improvement despite earnings remaining tied to cyclical demand. The stock settled into a "lower-growth, cyclical chemical with improving shareholder-return characteristics" narrative—less commodity and geopolitical headline risk, more focus on core chemicals profitability and capital allocation. The five-year pattern shows an uptrend into Feb-2022 peak (~€68.7), a pronounced downtrend through 2022–23 driven by Wintershall write-downs and energy shock, stabilization following the Wintershall→Harbour agreement (Dec-2023) and deal closing (Sep-2024), and multi-quarter consolidation into 2025–mid-2026 with the stock trading in the mid-40s. The net effect from the 2022 peak of approximately €68.69 to the current level represents a multi-year drawdown [65, 60, 21].
2026-07-01 — Latest price: 46.78
BASF operates across overlapping segments of the global chemical and materials landscape, competing directly against integrated commodity producers like Dow and LyondellBasell, specialty-chemicals firms including Evonik, Covestro, and Solvay, and crop-science companies such as Bayer and DuPont/Corteva. The company faces a layered risk structure: volatile feedstock and energy costs that compress margins unpredictably, cyclical demand from automotive, construction, and agricultural end-markets, regulatory and product-liability exposure that can shift capital requirements, and persistent price pressure from lower-cost regional competitors who operate with different cost structures.
BASF is a diversified global chemical company operating across commodity and specialty segments, competing directly with integrated producers like Dow and LyondellBasell, as well as specialists like Evonik, Covestro, and Arkema. The competitive landscape splits cleanly by segment: commodity chains live or die on feedstock and energy costs, while specialty, coatings, and agriscience businesses turn on innovation and how well they solve customer problems. The company faces persistent headwinds—feedstock and energy volatility, new low-cost capacity coming online, cyclical demand from end markets, and a regulatory environment that keeps tightening around environmental compliance.
| Company | Ticker |
|---|---|
| Dow Inc. | DOW.NYSE |
| LyondellBasell Industries N.V. | LYB.NYSE |
| Evonik Industries AG | EVK.XETRA |
| Arkema SA | AKE.PA |
| Solvay SA | SOLB.BR |
| PPG Industries, Inc. | PPG.NYSE |
| Linde plc | LIN.NYSE |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | BASF SE | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | -3.06% | -4.77% | -4.47% |
| 3M | -7.69% | -12.86% | -17.95% |
| 6M | +10.06% | +10.94% | +1.76% |
| 1Y | +16.63% | +13.20% | -5.24% |
| 3Y | +23.37% | -37.10% | -53.61% |
| 5Y | -5.27% | -64.87% | -88.96% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 23.9 | 0.7 | 1.2 | 7.2 |
| 1Y ago | 95.1 | 0.6 | 1.1 | 6.0 |
| 3Y ago | -21.6 | 0.5 | 1.1 | 5.1 |
| 5Y ago | 26.5 | 0.9 | 1.6 | 9.8 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 2.25 EUR | 4.11% | 4.7% |
| 2025 | 2.25 EUR | 5.07% | |
| 2024 | 3.40 EUR | 6.67% | |
| 2023 | 3.40 EUR | 7.08% | |
| 2022 | 3.40 EUR | 6.74% | |
| 2021 | 3.30 EUR | 4.68% | |
| 2020 | 3.30 EUR | 7.07% | |
| 2019 | 3.20 EUR | 4.39% | |
| 2018 | 3.10 EUR | 3.57% | |
| 2017 | 3.00 EUR | 3.35% | |
| 2016 | 2.90 EUR | 4.02% | |
| 2015 | 2.80 EUR | 3.13% | |
| 2014 | 2.70 EUR | 3.21% | |
| 2013 | 2.60 EUR | 3.58% | |
| 2012 | 2.50 EUR | 3.83% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 59.66B | 61.44B | 68.90B | 87.33B | 78.60B |
| Operating income (EBIT) | 2.56B | 3.38B | 3.81B | 6.76B | 7.40B |
| Net income | 1.62B | 1.30B | 225.00M | -627.00M | 5.52B |
| Free cash flow | 1.34B | 748.00M | 2.72B | 3.33B | 3.71B |
| Total assets | 78.02B | 80.42B | 79.93B | 84.47B | 87.38B |
| Equity | 33.19B | 35.60B | 35.28B | 36.60B | 40.79B |
| Net debt | 21.75B | 21.08B | 18.72B | 18.43B | 16.51B |